Publication Name	World Journal of Pharmacology
Manuscript ID	14199
Country	United States

Received	2014-09-24 08:27
Peer-Review Started	2014-09-24 17:26
To Make the First Decision	2014-10-14 17:50
Return for Revision	2014-10-17 12:17
Revised	2014-10-22 04:27
Second Decision	2014-12-11 08:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-12-17 16:53
Articles in Press	2014-12-17 16:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-03 11:45
Publish the Manuscript Online	2015-03-12 19:39

ISSN	2220-3192 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Microbiology
Manuscript Type	Review
Article Title	Antimicrobial resistance in clinically important biofilms
Manuscript Source	Invited Manuscript
All Author List	Fatemeh Rafii and Mark E Hart
Funding Agency and Grant Number
Corresponding Author	Fatemeh Rafii, Research Microbiologist, Division of Microbiology, National Center for Toxicological Research, FDA, Jefferson, AR 72079, United States. fatemeh.rafii@fda.hhs.gov
Key Words	Biofilm; Bacteria; Antimicrobial agent; Medical devices; Nosocomial infections; Resistance
Core Tip	Biofilm formation on host tissues and medically implanted devices is a major health problem, and the infections caused by bacteria in biofilms are hard to treat with antimicrobial agents. They are the cause of frequent and recurrent infections after the termination of antimicrobial treatments. The reasons for the recalcitrant nature of biofilms to antimicrobial treatment are varied and have been attributed to different factors, including impermeability of biofilms, slow rates of growth and metabolic activity, and the presence of small colonies and persisters. They have been the subject of many investigations that will be discussed in this minireview.
Publish Date	2015-03-12 19:39
Citation	Rafii F, Hart ME. Antimicrobial resistance in clinically important biofilms. World J Pharmacol 2015; 4(1): 31-46
URL	http://www.wjgnet.com/2220-3192/full/v4/i1/31.htm
DOI	http://dx.doi.org/10.5497/wjp.v4.i1.31

Full Article (PDF)	WJP-4-31.pdf
Full Article (Word)	WJP-4-31.doc
Manuscript File	14199-Review.doc
Answering Reviewers	14199-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14199-Conflict-of-interest statement.pdf
Copyright License Agreement	14199-Copyright assignment.pdf
Peer-review Report	14199-Peer review(s).pdf
Scientific Misconduct Check	14199-CrossCheck.jpg
Scientific Editor Work List	14199-Scientific editor work list.pdf